Axsome Therapeutics, Inc. (LON:0HKF)
London · Delayed Price · Currency is GBP · Price in USD 182.61
-3.18 (-1.71%)
Feb 12, 2026, 4:58 PM GMT
Axsome Therapeutics Market Cap
Axsome Therapeutics has a market cap or net worth of 6.88 billion as of February 12, 2026. Its market cap has increased by 72.32% in one year.
Market Cap
6.88B
Enterprise Value
6.80B
Revenue
417.55M
Ranking
n/a
PE Ratio
n/a
Stock Price
182.61
Market Cap Chart
Since November 19, 2015, Axsome Therapeutics's market cap has increased from 95.66M to 6.88B, an increase of 7,092.00%. That is a compound annual growth rate of 51.83%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 11, 2026 | 6.88B | 0.57% |
| Dec 31, 2025 | 6.84B | 108.87% |
| Dec 31, 2024 | 3.28B | 10.77% |
| Dec 29, 2023 | 2.96B | 6.36% |
| Dec 30, 2022 | 2.78B | 164.34% |
| Dec 31, 2021 | 1.05B | -52.81% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 219.68B |
| GSK plc | 87.00B |
| Haleon | 35.66B |
| Smith & Nephew | 10.94B |
| Convatec Group | 4.37B |
| Hikma Pharmaceuticals | 3.43B |
| Genus | 2.09B |
| HUTCHMED (China) | 1.88B |